Cyclooxygenase-2:: a therapeutic target in angiogenesis

被引:174
作者
Iñiguez, MA
Rodríguez, A
Volpert, OV
Fresno, M
Redondo, JM
机构
[1] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Fac Ciencias, E-28049 Madrid, Spain
[2] Ctr Nacl Invest Cardiovasc, E-28029 Madrid, Spain
[3] Dept Urol, Chicago, IL 60611 USA
[4] Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
关键词
D O I
10.1016/S1471-4914(02)00011-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiogenesis has a role in the pathogenesis of several disorders, including cancer, chronic inflammatory diseases and retinopathies. Recent evidence demonstrates that the production of prostanoids by cyclooxygenase-2 (COX-2) promotes the expression of pro-angiogenic factors. Furthermore, inhibition of COX-2 by non-steroidal anti-inflammatory drugs leads to restricted angiogenesis and downregulated production of pro-angiogenic factors, such as vascular endothelial growth factor and basic fibroblast growth factor. These findings suggest that COX enzymes could be important therapeutic targets in the treatment of pathological angiogenesis.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 61 条
[1]   HYPOXIC REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN RETINAL CELLS [J].
AIELLO, LP ;
NORTHRUP, JM ;
KEYT, BA ;
TAKAGI, H ;
IWAMOTO, MA .
ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (12) :1538-1544
[2]   Many actions of cyclooxygenase-2 in cellular dynamics and in cancer [J].
Cao, Y ;
Prescott, SM .
JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 190 (03) :279-286
[3]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[4]  
Cheng T, 1998, INVEST OPHTH VIS SCI, V39, P581
[5]  
Chulada PC, 2000, CANCER RES, V60, P4705
[6]   THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].
DAMATO, RJ ;
LOUGHNAN, MS ;
FLYNN, E ;
FOLKMAN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085
[7]  
Daniel TO, 1999, CANCER RES, V59, P4574
[8]   Cyclooxygenase inhibitors - current status and future prospects [J].
Dannhardt, G ;
Kiefer, W .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (02) :109-126
[9]   NSAIDs inhibit αVβ3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis [J].
Dormond, O ;
Foletti, A ;
Paroz, C ;
Rüegg, C .
NATURE MEDICINE, 2001, 7 (09) :1041-1047
[10]   Molecular and biological properties of vascular endothelial growth factor [J].
Ferrara, N .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (07) :527-543